p53 Mutations Cluster at Codon 249 in Hepatitis B Virus-positive Hepatocellular Carcinomas from China

Cancer Research

Volumn 52, Issue 6, 1992, Pages 1635-1638

  Zhou, Yi Zhong ^b   Butel, Janet S ^a   Slagle, Betty L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINA; CLINICAL ARTICLE; CODON; FEMALE; GENE MUTATION; GENETIC SCREENING; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL;

ADULT; CARCINOMA, HEPATOCELLULAR; CHINA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CODON; FEMALE; GENES, P53; HEPATITIS B VIRUS; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGE; MUTATION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026518760     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Di Bisceglie, A. M., and Hoofnagle, J. H. Hepatitis B virus infection and hepatocellular carcinoma: etiologic relationship and clinical implications. Prin. Pract. Oncol., 1:1-10, 1987.
2. Beasley, R. P., Hwang, L-Y., Lin, C-C., and Chien, C-S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of22707 men in Taiwan. Lancet, 2:1129-1133,1981.
3. Yeh, F-S., Yu, M. C., Mo, C-C., Luo, S., Tong, M. J., and Henderson, B. E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res., 49:2506-2509,1989.
4. Schroder, C. H., and Zentgraf, H. Hepatitis B virus related hepatocellular carcinoma: chronicity of infection-the opening to different pathways of malignant transformation? Biochim. Biophys. Acta, 1032:137-156,1990.
5. Szmuness, W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog. Med. Virol., 24:40-69,1978.
6. Harris, C. C. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells (Cold Spring Harbor), 2:146-148,1990.
7. Slagle, B. L., Lee, T-H., and Butel, J. S. Hepatitis B virus and hepatocellular carcinoma. Prog. Med. Virol., 39:167-203,1992.
8. Slagle, B. L., Zhou, Y-Z., and Butel, J. S. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res., 51:49-54, 1991.
9. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350:429-431,1991.
10. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350:427-428,1991.
11. Bressac, B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., and Ozturk, M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87:1973-1977,1990.
12. Ozturk, M. and collaborators. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338:1356-1359,1991.
13. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253:49-53,1991.
14. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351:453-456,1991.
15. Hosono, S., Lee, C-S., Chou, M-J., Yang, C-S., and Shih, C. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene, 6:237-243,1991.
16. Hayward, N. K., Walker, G. J., and Cooksley, W. G. E. Hepatocellular carcinoma mutation. Nature (Lond.), 352:764, 1991.
17. Zhou, Y-Z., Slagle, B. L., Donehower, L. A., vanTuinen, P., Ledbetter, D. H., and Butel, J. S. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J. Virol., 62:4224-4231,1988.
18. Zhou, Y-Z., Butel, J. S., Li, P-J., Finegold, M. J., and Melnick, J. L. Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. J. Natl. Cancer Inst., 79: 223-231, 1987.
19. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50:7717-7722,1990.
20. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Geary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342:705-708,1989.
21. Harris, C. C. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51:5023s-5044s, 1991.
22. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K., and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51:89-93,1991.
23. Walker, G. J., Hayward, N. K., Falvey, S., and Cooksley, W. G. E. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res., 51:4367-4370,1991.